Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 4706915, 16 pages
http://dx.doi.org/10.1155/2016/4706915
Research Article

Inhibition of TLR4 Signalling-Induced Inflammation Attenuates Secondary Injury after Diffuse Axonal Injury in Rats

1Department of Neurosurgery, The First Affiliated Hospital of Xi’an Jiaotong University, 277 West Yanta Road, Xi’an, Shaanxi 710061, China
2Department of Neurosurgery, The Second Affiliated Hospital of Xi’an Jiaotong University, No. 157 of Xiwu Road, Xi’an, Shaanxi 710004, China

Received 19 April 2016; Revised 17 June 2016; Accepted 19 June 2016

Academic Editor: Ulrich Eisel

Copyright © 2016 Yonglin Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Davceva, N. Basheska, and J. Balazic, “Diffuse axonal injury—a distinct clinicopathological entity in closed head injuries,” The American Journal of Forensic Medicine and Pathology, vol. 36, no. 3, pp. 127–133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. V. E. Johnson, W. Stewart, and D. H. Smith, “Axonal pathology in traumatic brain injury,” Experimental Neurology, vol. 246, pp. 35–43, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. Chung, J. A. Staal, G. H. McCormack et al., “Mild axonal stretch injury in vitro induces a progressive series of neurofilament alterations ultimately leading to delayed axotomy,” Journal of Neurotrauma, vol. 22, no. 10, pp. 1081–1091, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. B. J. Kelley, O. Farkas, J. Lifshitz, and J. T. Povlishock, “Traumatic axonal injury in the perisomatic domain triggers ultrarapid secondary axotomy and Wallerian degeneration,” Experimental Neurology, vol. 198, no. 2, pp. 350–360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. C. W. Christman, M. S. Grady, S. A. Walker, K. L. Holloway, and J. T. Povlishock, “Ultrastructural studies of diffuse axonal injury in humans,” Journal of Neurotrauma, vol. 11, no. 2, pp. 173–186, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. D. H. Smith, R. Hicks, and J. T. Povlishock, “Therapy development for diffuse axonal injury,” Journal of Neurotrauma, vol. 30, no. 5, pp. 307–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Lin and L. Wen, “Inflammatory response following diffuse axonal injury,” International Journal of Medical Sciences, vol. 10, no. 5, pp. 515–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Lee, S. Lee, I.-H. Cho, and S. J. Lee, “Toll-like receptors: sensor molecules for detecting damage to the nervous system,” Current Protein and Peptide Science, vol. 14, no. 1, pp. 33–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Bsibsi, R. Ravid, D. Gveric, and J. M. van Noort, “Broad expression of Toll-like receptors in the human central nervous system,” Journal of Neuropathology and Experimental Neurology, vol. 61, no. 11, pp. 1013–1021, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Wu, X. Zhang, M. Zhao, and A.-L. Zhou, “The role of the TLR4/NF-κB signaling pathway in Aβ accumulation in primary hippocampal neurons,” Sheng Li Xue Bao, vol. 67, no. 3, pp. 319–328, 2015. View at Google Scholar · View at Scopus
  11. T. Trotta, C. Porro, R. Calvello, and M. A. Panaro, “Biological role of Toll-like receptor-4 in the brain,” Journal of Neuroimmunology, vol. 268, no. 1-2, pp. 1–12, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. M. E. Gambuzza, V. Sofo, F. M. Salmeri, L. Soraci, S. Marino, and P. Bramanti, “Toll-like receptors in Alzheimer's disease: a therapeutic perspective,” CNS & Neurological Disorders—Drug Targets, vol. 13, no. 9, pp. 1542–1558, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Hua, H. Tang, J. Wang et al., “TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice,” Journal of Cerebral Blood Flow & Metabolism, vol. 35, no. 4, pp. 536–542, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. S.-C. Tang, T. V. Arumugam, X. Xu et al., “Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13798–13803, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-C. Wang, P.-F. Wang, H. Fang, J. Chen, X.-Y. Xiong, and Q.-W. Yang, “Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury,” Stroke, vol. 44, no. 9, pp. 2545–2552, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Ahmad, R. Crupi, M. Campolo, T. Genovese, E. Esposito, and S. Cuzzocrea, “Absence of TLR4 reduces neurovascular unit and secondary inflammatory process after traumatic brain injury in mice,” PLoS ONE, vol. 8, no. 3, Article ID e57208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Li, J. Song, X. Liu et al., “High expression of STIM1 in the early stages of diffuse axonal injury,” Brain Research, vol. 1495, pp. 95–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. R. A. Soslow, A. J. Dannenberg, D. Rush et al., “COX-2 is expressed in human pulmonary, colonic, and mammary tumors,” Cancer, vol. 89, no. 12, pp. 2637–2645, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Lehnardt, L. Massillon, P. Follett et al., “Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8514–8519, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Pang, T. Huang, J. Song, D. Li, Y. Zhao, and X. Ma, “Inhibiting HMGB1 with glycyrrhizic acid protects brain injury after DAI via its anti-inflammatory effect,” Mediators of Inflammation, vol. 2016, Article ID 4569521, 9 pages, 2016. View at Publisher · View at Google Scholar
  21. J. Song, X. Liu, J. Chen, F. Zhang, and L. Xi, “Dynamic changes in cerebral microcirculation and hypoxia in the early stages of diffuse axonal injury,” Neural Regeneration Research, vol. 6, no. 20, pp. 1530–1536, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. M. M. Buchanan, M. Hutchinson, L. R. Watkins, and H. Yin, “Toll-like receptor 4 in CNS pathologies,” Journal of Neurochemistry, vol. 114, no. 1, pp. 13–27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Ii, N. Matsunaga, K. Hazeki et al., “A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling,” Molecular Pharmacology, vol. 69, no. 4, pp. 1288–1295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Gárate, B. García-Bueno, J. L. M. Madrigal et al., “Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress,” Journal of Neuroinflammation, vol. 11, no. 8, pp. 1742–2094, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Gentleman, M. J. Nash, C. J. Sweeting, D. I. Graham, and G. W. Roberts, “β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury,” Neuroscience Letters, vol. 160, no. 2, pp. 139–144, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Zhang, H. Li, T. Li et al., “TLR4 inhibitor resatorvid provides neuroprotection in experimental traumatic brain injury: implication in the treatment of human brain injury,” Neurochemistry International, vol. 75, pp. 11–18, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. C.-G. Chen, T.-H. Hung, C. Y. Lee et al., “Berberine protects against neuronal damage via suppression of glia-mediated inflammation in traumatic brain injury,” PLoS ONE, vol. 9, no. 12, Article ID e115694, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-C. Chen, T.-H. Hung, Y.-H. Wang et al., “Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-κB signaling after experimental traumatic brain injury,” PLoS ONE, vol. 7, no. 1, Article ID e30294, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Mietelska-Porowska, U. Wasik, M. Goras, A. Filipek, and G. Niewiadomska, “Tau protein modifications and interactions: their role in function and dysfunction,” International Journal of Molecular Sciences, vol. 15, no. 3, pp. 4671–4713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Burguillos, M. Svensson, T. Schulte et al., “Microglia-secreted galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation,” Cell Reports, vol. 10, no. 9, pp. 1626–1638, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. M. L. Block, L. Zecca, and J.-S. Hong, “Microglia-mediated neurotoxicity: uncovering the molecular mechanisms,” Nature Reviews Neuroscience, vol. 8, no. 1, pp. 57–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. T. F. Pais, C. Figueiredo, R. Peixoto, M. H. Braz, and S. Chatterjee, “Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway,” Journal of Neuroinflammation, vol. 5, no. 1, article 43, pp. 1–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. S.-C. Tang, J. D. Lathia, P. K. Selvaraj et al., “Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid β-peptide and the membrane lipid peroxidation product 4-hydroxynonenal,” Experimental Neurology, vol. 213, no. 1, pp. 114–121, 2008. View at Publisher · View at Google Scholar · View at Scopus